Aeterna Faces Shareholder Suit Over Growth Hormone Drug
By Martin Bricketto ( November 20, 2014, 7:54 PM EST) -- Aeterna Zentaris Inc. was hit with a putative class action in New Jersey federal court on Wednesday claiming that the Canadian pharmaceutical company inflated its stock by misleading the investing public about the prospects for a drug to help diagnose adult growth hormone deficiency....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.